Scientists at the Laboratoire des Maladies Neurodégénératives (CNRS/CEA/Université Paris-Saclay) and the Neurocentre Magendie (INSERM/Université de Bordeaux) have just shown that a metabolic pathway plays a determining ...
Mar 3, 2020
0
13
Tracking wearable sensors, filming the patients performing routine exercises, or examining their handwriting—which is better for Parkinson's detection? Researchers at Skoltech performed a comparative study of these three ...
Jul 14, 2022
0
22
Spicy food challenges are all the rage these days, but can munching red hot peppers and sizzling hot sauces harm you?
Jul 8, 2022
0
47
Three days after testing positive for COVID-19, "everything tasted like cardboard," recalls 38-year-old Elizabeth Medina, who lost her sense of taste and smell at the start of the pandemic. A year later, she fears she will ...
Mar 28, 2021
0
28
Heart disease remains the largest killer in Australia and around the world. A new study has shown that a protein therapy- recombinant human platelet-derived growth factor-AB (rhPDGF-AB) - could improve outcomes following ...
Jan 2, 2020
0
332
A common and relatively mild malady is yet another symptom people should watch for in the fight against COVID-19, experts say.
May 3, 2023
0
1
In an effort to address widespread concerns related to testosterone deficiency (TD) and its treatment with testosterone therapy, a group of international experts has developed a set of resolutions and conclusions to provide ...
Jun 21, 2016
0
444
Men with untreated high blood pressure have poorer penile blood flow than those with normal blood pressure, according to research presented today at ESC Congress 2020. The differences disappeared with blood pressure medication. ...
Aug 28, 2020
0
8
A team of researchers from Stanford University in the U.S. and Southern University of Science and Technology in China has found evidence that suggests metastasis of cancerous tumors may get its start much earlier than previously ...
Researchers at the Medical Faculty of the Technische Universität Dresden (TUD) and the Heinrich Pette Institute (HPI), Leibniz Institute for Experimental Virology succeeded in developing a designer recombinase (Brec1) that ...
Feb 22, 2016
0
131
